Pappas Capital Strengthens Investment Team With Appointments Of Cookie Yu And Gilbert Kinsey To Principal

SAS and Pappas Capital partner to propel AgTech startups with analytics

CARY, N.C., Oct. 20, 2021 -- Two North Carolina companies, analytics leader SAS and venture investment firm Pappas Capital, are joining forces to help advance the state as a global leader in agricultural technology. The state's AgTech sector is ripe for continued growth and innovation, and technologies such as artificial intelligence, machine learning and analytics are driving innovation in digital agriculture. The collaboration between SAS and Pappas will allow select NC agriculture and food startups to gain guidance and executive leadership from Pappas and access to industry-leading analytics software, data science expertise and cloud services from SAS.

Pappas Capital Strengthens Specialized Fund Management Business With Appointment Of Karen LeVert As Venture Partner

RESEARCH TRIANGLE PARK, NC, Feb. 3, 2020 -- Pappas Capital, a leading investor in early-stage life sciences companies, has appointed Karen LeVert as Venture Partner to help lead the expansion of the firm's Specialized Fund Management business, with a focus on identifying attractive investment opportunities in agricultural and other related technologies. Ms. LeVert has a proven track record of progressing early stage technologies from university research labs to commercialization, and most recently co-founded two independent innovation labs, Southeast TechInventures, Inc. (STI) and Ag TechInventures, LLC (AgTI).

Alex Arfaei Joins Pappas Capital As Partner

RESEARCH TRIANGLE PARK, N.C., Sept. 11, 2019 -- Pappas Capital, a leading investor in early-stage life sciences companies, announced today that Alex Arfaei has joined the firm as a Partner of Pappas Ventures. In his role, Mr. Arfaei will be responsible for helping to identify and evaluate investment opportunities for the firm's venture capital business. Previously, Mr. Arfaei served as a Managing Director with BMO Capital Markets, where he was a senior equity research analyst covering major pharmaceutical and biotechnology companies.

Wake Forest Baptist Medical Center Creates $15 Million Program to Develop Life Science Technologies

WINSTON-SALEM, N.C. – Oct. 7, 2015 – Wake Forest Baptist Medical Center today announced the creation of a Technology Development Program, a $15 million program to develop the ideas, discoveries and inventions of the faculty and staff of the Medical Center into life science technologies having the potential to benefit patients in the community and worldwide. The new program is in partnership with leading life science investment firm Pappas Capital, in Durham. Funds will be managed by Pappas in collaboration with Wake Forest Innovations to advance clinically important life science technologies for licensing to established companies or startups.